These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35818328)

  • 1. LINC00963 May Be Associated with a Poor Prognosis in Patients with Cervical Cancer.
    Chang A; Wang P; Ren J
    Med Sci Monit; 2022 Jul; 28():e935070. PubMed ID: 35818328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of CLCA2 and the correlating with immune infiltrates in patients with cervical squamous cell carcinoma: A bioinformatics analysis.
    Yang X; Cao JL; Yang FN; Li XF; Tao LM; Wang F
    Taiwan J Obstet Gynecol; 2021 May; 60(3):480-486. PubMed ID: 33966732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZNF695, A Potential Prognostic Biomarker, Correlates with Im mune Infiltrates in Cervical Squamous Cell Carcinoma and Endoce rvical Adenocarcinoma: Bioinformatic Analysis and Experimental Verification.
    Ding X; Wan A; Qi X; Jiang K; Liu Z; Chen B
    Curr Gene Ther; 2024; 24(5):441-452. PubMed ID: 38441026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased Expression of NUSAP1 Predicts Poor Overall Survival in Cervical Cancer.
    Xie Q; Ou-Yang W; Zhang M; Wang H; Yue Q
    J Cancer; 2020; 11(10):2852-2863. PubMed ID: 32226503
    [No Abstract]   [Full Text] [Related]  

  • 5. Fatty acid synthase (FASN) inhibits the cervical squamous cell carcinoma (CESC) progression through the Akt/mTOR signaling pathway.
    Lin Q; Jiang Y; Zhou F; Zhang Y
    Gene; 2023 Jan; 851():147023. PubMed ID: 36375657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer.
    Wang J; Huang J; Ding H; Ma J; Zhong H; Wang F; Chen Y; Peng H
    BMC Cancer; 2023 Oct; 23(1):929. PubMed ID: 37784026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of S1PR2 is correlated with poor prognosis and immune infiltrates in cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Zhang Y; Wang H; Lu J; Lv Q; Yun B; Ge Z; Yan L
    Int J Immunopathol Pharmacol; 2023; 37():3946320231178131. PubMed ID: 37232164
    [No Abstract]   [Full Text] [Related]  

  • 8. Upregulation of CCT3 promotes cervical cancer progression through FN1.
    Dou L; Zhang X
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34651664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of potential therapeutic and prognostic value of CXC chemokines in cervical squamous cell carcinoma and endocervical adenocarcinoma based on bioinformatics analysis.
    Wu C; Ma C; Yuan J; Zhou P
    Math Biosci Eng; 2021 Sep; 18(6):8201-8222. PubMed ID: 34814296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value and Immune Infiltration of HPV-Related Genes in the Immune Microenvironment of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
    Gan Q; Mao L; Shi R; Chang L; Wang G; Cheng J; Chen R
    Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of clinical prognosis and biological significance of CNIH4 in cervical cancer.
    Wang J; Wang S; Wang J; Huang J; Lu H; Pan B; Pan H; Song Y; Deng Q; Jin X; Shi G
    Cancer Med; 2023 Dec; 12(24):22381-22394. PubMed ID: 38087815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLOD2 Is a Potent Prognostic Marker and Associates with Immune Infiltration in Cervical Cancer.
    Li G; Wang X; Liu G
    Biomed Res Int; 2021; 2021():5512340. PubMed ID: 34258263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of SRPK1 (serine/arginine-rich protein-specific kinase 1) is associated with progression and unfavorable prognosis in cervical squamous cell carcinoma.
    Dong Z; Chang X; Xie L; Wang Y; Hou Y
    Bioengineered; 2022 Mar; 13(3):6100-6112. PubMed ID: 35192432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Expression of TMEM33 Predicts Poor Prognosis and Promotes Cell Proliferation in Cervical Cancer.
    Chen H; Zhao X; Li Y; Zhang S; Wang Y; Wang L; Ma W
    Front Genet; 2022; 13():908807. PubMed ID: 35832191
    [No Abstract]   [Full Text] [Related]  

  • 15. Gene signatures, immune infiltration, and drug sensitivity based on a comprehensive analysis of m6a RNA methylation regulators in cervical cancer.
    Lu X; Li R; Ying Y; Zhang W; Wang W
    J Transl Med; 2022 Sep; 20(1):385. PubMed ID: 36058934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TPM3: a novel prognostic biomarker of cervical cancer that correlates with immune infiltration and promotes malignant behavior
    Zhao YC; Wang TJ; Qu GH; She LZ; Cui J; Zhang RF; Qu HD
    Am J Cancer Res; 2023; 13(7):3123-3139. PubMed ID: 37559998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Stemness-Related Genes for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma by Integrated Bioinformatics Analysis.
    Guo H; Wang S; Ju M; Yan P; Sun W; Li Z; Wu S; Lin R; Xian S; Yang D; Wang J; Huang Z
    Front Cell Dev Biol; 2021; 9():642724. PubMed ID: 33842467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RILPL2 is associated with the progression and prognosis of cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Dong Y; Wen W; Yuan T; Liu L; Li X
    Am J Transl Res; 2023; 15(2):1072-1084. PubMed ID: 36915776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metallothionein-like 5 expression is correlated with poor prognosis and promotes proliferation of cervical squamous cell carcinoma.
    Huang Y; Wu Q; Tan X
    Bioengineered; 2022 Mar; 13(3):6955-6965. PubMed ID: 35249447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review and meta-analysis of long noncoding RNA 00963 expression and prognosis and clinicopathological characteristic in human cancers.
    He J; Wang Z; Wang Y; Liu F; Fu L; Jiang X; Wang P; Chen H; Hu M; Cai H
    Pathol Res Pract; 2023 Feb; 242():154291. PubMed ID: 36696806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.